Article(id=1325225421171720729, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325225021030932569, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2026.04.006, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1746979200000, receivedDateStr=2025-05-12, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887961905, onlineDateStr=2026-11-05, pubDate=1775750400000, pubDateStr=2026-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887961905, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887961905, creator=13701087609, updateTime=1793887961905, updator=13701087609, issue=Issue{id=1325225021030932569, tenantId=1146029695717560320, journalId=1319690259887390882, year='2026', volume='57', issue='4', pageStart='377', pageEnd='498', issueExtLink='null', onlineDate='null', pubDate='1775750400000', pubDateStr='2026-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887866504, creator='13701087609', updateTime=1793946144656, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325469457388273914, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325225021030932569, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325469457388273915, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325225021030932569, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=413, endPage=418, ext={EN=ArticleExt(id=1325225421423378970, articleId=1325225421171720729, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Improved Synthesis of Pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=

The synthetic process of pyrrolo[2, 1-f][1, 2, 4]triazin-4(3H)-one (1) was optimized via a four-step reaction sequence. Starting from 2, 5-dimethoxytetrahydrofuran (6) and tert-butoxycarbonyl hydrazine, tert-butyl(1H-pyrrol-1-yl)carbamate (7) was obtained via a Clauson-Kaas pyrrole synthesis. Subsequent formamidation of compound 7 with chlorosulfonyl isocyanate afforded the key intermediate tert-butyl (2-carbamoyl-1H-pyrrol-1-yl)carbamate (9).Deprotection of 9 with hydrogen chloride followed by cyclization with trimethyl orthoformate yielded the target 1 with an overall yield of 60.7%(based on tert-butoxycarbonyl hydrazine) and a purity of 99.51%. This process achieves the “one-pot method” synthesis of key intermediate 9 from compound 7 . All intermediates were purified via simple crystallization or slurrying, resulting in a straightforward, robust, and industrially viable protocol.

, authors=Mao SUN1, Xianji LIU1, Yuanyuan LIU2, Chuanling WANG2, Chen YAN1, *, authorsList=Mao SUN, Xianji LIU, Yuanyuan LIU, Chuanling WANG, Chen YAN, authorCompany=null, correspAuthors=Chen YAN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325225421746340379, articleId=1325225421171720729, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=吡咯并[2,1-f][1,2,4]三嗪-4(3H)-酮的合成工艺优化, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

对吡咯并[2,1-f][1,2,4]三嗪-4(3H)-酮(1)的合成工艺进行优化,共计4步反应。以2,5-二甲氧基四氢呋喃(6)与叔丁氧羰基肼为起始原料,经Clauson-Kaas吡咯合成反应得到(1H-吡咯-1-基)氨基甲酸叔丁酯(7);7与氯磺酰异氰酸酯发生甲酰胺化反应,得(2-氨基甲酰基-1H-吡咯-1-基)氨基甲酸叔丁酯(9);9通过氯化氢脱保护基后,与原甲酸三甲酯发生环化反应,得目标产物1。总收率60.7%(以叔丁氧羰基肼计),纯度99.51%。该工艺实现了从化合物7到9的“一锅法”合成。各中间体均通过简便的结晶或打浆完成纯化,整体流程操作简捷、稳定、可靠,为工业化生产提供了可靠的技术方案。

, authors=孙茂1, 刘显吉1, 刘媛媛2, 王传令2, 晏晨1, *, authorsList=孙茂, 刘显吉, 刘媛媛, 王传令, 晏晨, authorCompany=null, correspAuthors=晏晨, authorNote=

孙茂,主管药师,从事有机合成与药物化学研究。

, correspAuthorsNote=
晏晨,主任药师,从事天然产物化学与药物化学研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=qTlbOlgG65+eoW+sQ+2I9Q==, magXml=Uj3Kqg0xoFtq89ansQitQg==, pdfUrl=null, pdf=giYPix8hP1RKRyoprxsgPQ==, pdfFileSize=1001638, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=WJ+57u4IuLC7Ab9XpfhtrA==, mapNumber=null, fund=null)}, authors=[Author(id=1325225422161576483, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225422245462565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225422161576483, language=EN, stringName=Mao SUN, firstName=Mao, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225423914795558, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225422161576483, language=CN, stringName=孙茂, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000, bio={"content":"

孙茂,主管药师,从事有机合成与药物化学研究。

"}, bioImg=null, bioContent=

孙茂,主管药师,从事有机合成与药物化学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225421981221404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=1., ext=[AuthorCompanyExt(id=1325225421989610013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000), AuthorCompanyExt(id=1325225421997998622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000)])]), Author(id=1325225423990293032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225424082567722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225423990293032, language=EN, stringName=Xianji LIU, firstName=Xianji, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225424166453803, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225423990293032, language=CN, stringName=刘显吉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225421981221404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=1., ext=[AuthorCompanyExt(id=1325225421989610013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000), AuthorCompanyExt(id=1325225421997998622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000)])]), Author(id=1325225424321643053, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225424405529135, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225424321643053, language=EN, stringName=Yuanyuan LIU, firstName=Yuanyuan, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Guizhou Puzhiyuan Biotechnology Co., Ltd.,Anshun 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225424673964592, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225424321643053, language=CN, stringName=刘媛媛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225422069301791, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=2., ext=[AuthorCompanyExt(id=1325225422077690400, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225422069301791, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Guizhou Puzhiyuan Biotechnology Co., Ltd.,Anshun 561000), AuthorCompanyExt(id=1325225422086079009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225422069301791, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000)])]), Author(id=1325225424741073458, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225424816570932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225424741073458, language=EN, stringName=Chuanling WANG, firstName=Chuanling, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Guizhou Puzhiyuan Biotechnology Co., Ltd.,Anshun 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225425101783605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225424741073458, language=CN, stringName=王传令, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225422069301791, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=2., ext=[AuthorCompanyExt(id=1325225422077690400, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225422069301791, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Guizhou Puzhiyuan Biotechnology Co., Ltd.,Anshun 561000), AuthorCompanyExt(id=1325225422086079009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225422069301791, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000)])]), Author(id=1325225425160503863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325225425248584249, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225425160503863, language=EN, stringName=Chen YAN, firstName=Chen, middleName=null, lastName=YAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225425508631098, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225425160503863, language=CN, stringName=晏晨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225421981221404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=1., ext=[AuthorCompanyExt(id=1325225421989610013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000), AuthorCompanyExt(id=1325225421997998622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000)])])], keywords=[Keyword(id=1325225425621877307, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, language=EN, orderNo=1, keyword=pyrrolo[2,1-f][1,2,4]triazine), Keyword(id=1325225425705763388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, language=EN, orderNo=2, keyword=chlorosulfonyl isocyanate), Keyword(id=1325225425970004541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, language=EN, orderNo=3, keyword=intermediate), Keyword(id=1325225426049696318, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, language=EN, orderNo=4, keyword=process optimization), Keyword(id=1325225426116805183, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, language=CN, orderNo=1, keyword=吡咯并[2,1-f][1,2,4]三嗪), Keyword(id=1325225426246828608, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, language=CN, orderNo=2, keyword=氯磺酰异氰酸酯), Keyword(id=1325225426322326081, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, language=CN, orderNo=3, keyword=中间体), Keyword(id=1325225426406212162, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, language=CN, orderNo=4, keyword=工艺优化)], refs=[Reference(id=1325225428474004038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=GE T, CINTRAT J C. Pyrrolotriazinone as an underexplored scaffold in drug discovery [J]. Pharmaceuticals(Basel),2021, 14(12):1275., articleTitle=null, refAbstract=null), Reference(id=1325225428578861639, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=SATHE B D, JAISWAL S, KUMAR D, et al. Design and development of novel hybrids based on pyrrolo[2,1-f]-[1,2,4]triazine and 1-(methylpiperidin-4-yl) aniline-based analogs:exploring the utility as anticancer agents via MERTK inhibition [J]. Chem Biol Drug Des, 2024, 104(6):e70023-e70036., articleTitle=null, refAbstract=null), Reference(id=1325225428654359112, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=JIA H, DAI G X, SU W G, et al. Discovery, optimization,and evaluation of potent and highly selective PI3Kγ-PI3Kδ dual inhibitors [J]. J Med Chem, 2019, 62(10):4936-4948., articleTitle=null, refAbstract=null), Reference(id=1325225428767605321, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=LOUIS J L, RAJEEV S B, KYOUNG S K, et al. Pyrrolotriazinone compounds and their use to treat diseases:WO, 2003099286A1 [P]. 2003-12-04., articleTitle=null, refAbstract=null), Reference(id=1325225428889240138, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=YARLAGADDA S B, POORAN C, PRAVIN L K, et al. Therapeutic agents:WO, 2010014930A2 [P]. 2010-02-04., articleTitle=null, refAbstract=null), Reference(id=1325225428973126219, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=SAITO T, OBITSU T, KOHNOH, et al. Pyrrolo[1,2-b]-pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1(CRF1)receptor antagonists [J]. Bioorg Med Chem, 2012, 20(2):1122-1138., articleTitle=null, refAbstract=null), Reference(id=1325225429073789516, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=BRACEG N, CHOVATIA P T, FOULKES G, et al. Benzoxazinone derivatives and analogues thereof as modulatorose TNF activity:US, 2018/0134728A1 [P]. 2018-05-17., articleTitle=null, refAbstract=null), Reference(id=1325225429199618637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=CAI Z, ZHANG Y, BORZILLERI R M, et al. Discovery of brivanib alaninate [(S)-[(R)-1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]-triazin-6-yloxy]propan-2-yl]2-aminopropanoate], a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor(BMS-540215) [J]. J Med Chem, 2008, 51(6):1976-1980., articleTitle=null, refAbstract=null), Reference(id=1325225429287699022, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=GAVAIA A V, FINK B E, FAIRFAX D J, et al. Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)-methyl]-1h-indazol-5-ylamino]-5-methylpyrrolo[2,1-f]-[1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester(BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinases [J]. J Med Chem, 2009, 52(21):6527-6530., articleTitle=null, refAbstract=null), Reference(id=1325225429384168015, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=HUNT J T, MITT T, BORZILLERI R, et al. Discovery of the pyrrolo[2,1-f][1,2,4]triazine nucleus as a new kinase inhibitor template [J]. J Med Chem, 2004, 47(16):4054-4509., articleTitle=null, refAbstract=null), Reference(id=1325225429451276880, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=PATIL S A, OTTER B A, KLEIN R S. Synthesis of pyrrolo[2,1-f][1,2,4]triazine congeners of nucleic acid purines via the N-amination of 2-substituted pyrroles [J]. J Heterocyclic Chem, 1994, 31(4):781-785., articleTitle=null, refAbstract=null), Reference(id=1325225429526774353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=CLAUSON-KASS N, TYLE Z. Preparation of cis- and trans 2,5-dimethoxy-2-(acetamidomethyl)-2,5-dihydrofuran,of cis- and trans 2,5-dimethoxy-2-(acetamidomethyl)-tetrahydrofuran and of 1-phenyl-2-(acetamidomethyl)-pyrrole[J]. Acta Chem Scand, 1952, 6:667-670., articleTitle=null, refAbstract=null), Reference(id=1325225429602271826, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=KAROUSIS N, LIEBSCHER J, VARVOUNIS G. Synthesis of (E)-3-(1H-Pyrrol-3-yl)prop-2-ene derivatives using organo-phosphorous reagents [J]. Paper, 2006, 9:1494-1498., articleTitle=null, refAbstract=null), Reference(id=1325225429669380691, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=MEHTA G, DHAR D N, SURI S. Reaction of indoles with chlorosulphonyl isocyanate; a versatile route to 3-substituted indoles [J]. Synthesis, 1978, 5:374-376., articleTitle=null, refAbstract=null), Reference(id=1325225429770043988, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=TURNBULL K, GROSS K C, HALL T A. Direct carboxamidation of sydnones with chlorosulfonyl isocyanate[J]. Synthetic Commun, 1998, 28(5):931-937., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325225426523652675, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, awardId=安市科人〔2024〕8号, language=CN, fundingSource=安顺市“两城三基地”青年科技人才培养项目(安市科人〔2024〕8号), fundOrder=null, country=null), Fund(id=1325225426662064708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, awardId=安市科医自〔2026〕2号, language=CN, fundingSource=安顺市人民医院2026年度市级科研重点项目(安市科医自〔2026〕2号), fundOrder=null, country=null), Fund(id=1325225426771116613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, awardId=安市科平〔2024〕04号, language=CN, fundingSource=安顺市科技局平台建设项目(安市科平〔2024〕04号), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325225421981221404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=1., ext=[AuthorCompanyExt(id=1325225421989610013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000), AuthorCompanyExt(id=1325225421997998622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000)]), AuthorCompany(id=1325225422069301791, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=2., ext=[AuthorCompanyExt(id=1325225422077690400, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225422069301791, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Guizhou Puzhiyuan Biotechnology Co., Ltd.,Anshun 561000), AuthorCompanyExt(id=1325225422086079009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225422069301791, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.04.006, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.04.006, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2026.04.006, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2026.04.006, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1775750400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
吡咯并[2,1-f][1,2,4]三嗪-4(3H)-酮的合成工艺优化
孙茂 1 , 刘显吉 1 , 刘媛媛 2 , 王传令 2 , 晏晨 1, *
中国医药工业杂志 | 研究论文 2026,57(4): 413-418
收起
收藏切换
中国医药工业杂志 |研究论文 2026 , 57 (4) : 413 -418
吡咯并[2,1-f][1,2,4]三嗪-4(3H)-酮的合成工艺优化
全屏
[Author(id=1325225422161576483, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225422245462565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225422161576483, language=EN, stringName=Mao SUN, firstName=Mao, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225423914795558, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225422161576483, language=CN, stringName=孙茂, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000, bio={"content":"

孙茂,主管药师,从事有机合成与药物化学研究。

"}, bioImg=null, bioContent=

孙茂,主管药师,从事有机合成与药物化学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225421981221404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=1., ext=[AuthorCompanyExt(id=1325225421989610013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000), AuthorCompanyExt(id=1325225421997998622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000)])]), Author(id=1325225423990293032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225424082567722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225423990293032, language=EN, stringName=Xianji LIU, firstName=Xianji, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225424166453803, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225423990293032, language=CN, stringName=刘显吉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225421981221404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=1., ext=[AuthorCompanyExt(id=1325225421989610013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000), AuthorCompanyExt(id=1325225421997998622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000)])]), Author(id=1325225424321643053, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225424405529135, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225424321643053, language=EN, stringName=Yuanyuan LIU, firstName=Yuanyuan, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Guizhou Puzhiyuan Biotechnology Co., Ltd.,Anshun 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225424673964592, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225424321643053, language=CN, stringName=刘媛媛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225422069301791, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=2., ext=[AuthorCompanyExt(id=1325225422077690400, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225422069301791, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Guizhou Puzhiyuan Biotechnology Co., Ltd.,Anshun 561000), AuthorCompanyExt(id=1325225422086079009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225422069301791, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000)])]), Author(id=1325225424741073458, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225424816570932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225424741073458, language=EN, stringName=Chuanling WANG, firstName=Chuanling, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Guizhou Puzhiyuan Biotechnology Co., Ltd.,Anshun 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225425101783605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225424741073458, language=CN, stringName=王传令, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225422069301791, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=2., ext=[AuthorCompanyExt(id=1325225422077690400, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225422069301791, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Guizhou Puzhiyuan Biotechnology Co., Ltd.,Anshun 561000), AuthorCompanyExt(id=1325225422086079009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225422069301791, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000)])]), Author(id=1325225425160503863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325225425248584249, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225425160503863, language=EN, stringName=Chen YAN, firstName=Chen, middleName=null, lastName=YAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225425508631098, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, authorId=1325225425160503863, language=CN, stringName=晏晨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225421981221404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, xref=1., ext=[AuthorCompanyExt(id=1325225421989610013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000), AuthorCompanyExt(id=1325225421997998622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225421171720729, companyId=1325225421981221404, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000)])])]
孙茂1, 刘显吉1, 刘媛媛2, 王传令2, 晏晨1, *
作者信息
  • 1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000
  • 2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000
通讯作者:
晏晨,主任药师,从事天然产物化学与药物化学研究。
作者简介:

孙茂,主管药师,从事有机合成与药物化学研究。

Improved Synthesis of Pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one
Mao SUN1, Xianji LIU1, Yuanyuan LIU2, Chuanling WANG2, Chen YAN1, *
Affiliations
  • 1.Pharmaceutical Lab., People’s Hospital of Anshun City Guizhou Province, Anshun 561000
  • 2.Guizhou Puzhiyuan Biotechnology Co., Ltd.,Anshun 561000
出版时间: 2026-04-10 doi: 10.16522/j.cnki.cjph.2026.04.006
文章导航
收藏切换

对吡咯并[2,1-f][1,2,4]三嗪-4(3H)-酮(1)的合成工艺进行优化,共计4步反应。以2,5-二甲氧基四氢呋喃(6)与叔丁氧羰基肼为起始原料,经Clauson-Kaas吡咯合成反应得到(1H-吡咯-1-基)氨基甲酸叔丁酯(7);7与氯磺酰异氰酸酯发生甲酰胺化反应,得(2-氨基甲酰基-1H-吡咯-1-基)氨基甲酸叔丁酯(9);9通过氯化氢脱保护基后,与原甲酸三甲酯发生环化反应,得目标产物1。总收率60.7%(以叔丁氧羰基肼计),纯度99.51%。该工艺实现了从化合物7到9的“一锅法”合成。各中间体均通过简便的结晶或打浆完成纯化,整体流程操作简捷、稳定、可靠,为工业化生产提供了可靠的技术方案。

吡咯并[2,1-f][1,2,4]三嗪  /  氯磺酰异氰酸酯  /  中间体  /  工艺优化

The synthetic process of pyrrolo[2, 1-f][1, 2, 4]triazin-4(3H)-one (1) was optimized via a four-step reaction sequence. Starting from 2, 5-dimethoxytetrahydrofuran (6) and tert-butoxycarbonyl hydrazine, tert-butyl(1H-pyrrol-1-yl)carbamate (7) was obtained via a Clauson-Kaas pyrrole synthesis. Subsequent formamidation of compound 7 with chlorosulfonyl isocyanate afforded the key intermediate tert-butyl (2-carbamoyl-1H-pyrrol-1-yl)carbamate (9).Deprotection of 9 with hydrogen chloride followed by cyclization with trimethyl orthoformate yielded the target 1 with an overall yield of 60.7%(based on tert-butoxycarbonyl hydrazine) and a purity of 99.51%. This process achieves the “one-pot method” synthesis of key intermediate 9 from compound 7 . All intermediates were purified via simple crystallization or slurrying, resulting in a straightforward, robust, and industrially viable protocol.

pyrrolo[2,1-f][1,2,4]triazine  /  chlorosulfonyl isocyanate  /  intermediate  /  process optimization
孙茂, 刘显吉, 刘媛媛, 王传令, 晏晨. 吡咯并[2,1-f][1,2,4]三嗪-4(3H)-酮的合成工艺优化. 中国医药工业杂志, 2026 , 57 (4) : 413 -418 . DOI: 10.16522/j.cnki.cjph.2026.04.006
Mao SUN, Xianji LIU, Yuanyuan LIU, Chuanling WANG, Chen YAN. Improved Synthesis of Pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (4) : 413 -418 . DOI: 10.16522/j.cnki.cjph.2026.04.006
  • 安顺市“两城三基地”青年科技人才培养项目(安市科人〔2024〕8号)
  • 安顺市人民医院2026年度市级科研重点项目(安市科医自〔2026〕2号)
  • 安顺市科技局平台建设项目(安市科平〔2024〕04号)
参考文献 引证文献
排序方式:
[1]
GE T, CINTRAT J C. Pyrrolotriazinone as an underexplored scaffold in drug discovery [J]. Pharmaceuticals(Basel),2021, 14(12):1275.
[2]
SATHE B D, JAISWAL S, KUMAR D, et al. Design and development of novel hybrids based on pyrrolo[2,1-f]-[1,2,4]triazine and 1-(methylpiperidin-4-yl) aniline-based analogs:exploring the utility as anticancer agents via MERTK inhibition [J]. Chem Biol Drug Des, 2024, 104(6):e70023-e70036.
[3]
JIA H, DAI G X, SU W G, et al. Discovery, optimization,and evaluation of potent and highly selective PI3Kγ-PI3Kδ dual inhibitors [J]. J Med Chem, 2019, 62(10):4936-4948.
[4]
LOUIS J L, RAJEEV S B, KYOUNG S K, et al. Pyrrolotriazinone compounds and their use to treat diseases:WO, 2003099286A1 [P]. 2003-12-04.
[5]
YARLAGADDA S B, POORAN C, PRAVIN L K, et al. Therapeutic agents:WO, 2010014930A2 [P]. 2010-02-04.
[6]
SAITO T, OBITSU T, KOHNOH, et al. Pyrrolo[1,2-b]-pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1(CRF1)receptor antagonists [J]. Bioorg Med Chem, 2012, 20(2):1122-1138.
[7]
BRACEG N, CHOVATIA P T, FOULKES G, et al. Benzoxazinone derivatives and analogues thereof as modulatorose TNF activity:US, 2018/0134728A1 [P]. 2018-05-17.
[8]
CAI Z, ZHANG Y, BORZILLERI R M, et al. Discovery of brivanib alaninate [(S)-[(R)-1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]-triazin-6-yloxy]propan-2-yl]2-aminopropanoate], a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor(BMS-540215) [J]. J Med Chem, 2008, 51(6):1976-1980.
[9]
GAVAIA A V, FINK B E, FAIRFAX D J, et al. Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)-methyl]-1h-indazol-5-ylamino]-5-methylpyrrolo[2,1-f]-[1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester(BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinases [J]. J Med Chem, 2009, 52(21):6527-6530.
[10]
HUNT J T, MITT T, BORZILLERI R, et al. Discovery of the pyrrolo[2,1-f][1,2,4]triazine nucleus as a new kinase inhibitor template [J]. J Med Chem, 2004, 47(16):4054-4509.
[11]
PATIL S A, OTTER B A, KLEIN R S. Synthesis of pyrrolo[2,1-f][1,2,4]triazine congeners of nucleic acid purines via the N-amination of 2-substituted pyrroles [J]. J Heterocyclic Chem, 1994, 31(4):781-785.
[12]
CLAUSON-KASS N, TYLE Z. Preparation of cis- and trans 2,5-dimethoxy-2-(acetamidomethyl)-2,5-dihydrofuran,of cis- and trans 2,5-dimethoxy-2-(acetamidomethyl)-tetrahydrofuran and of 1-phenyl-2-(acetamidomethyl)-pyrrole[J]. Acta Chem Scand, 1952, 6:667-670.
[13]
KAROUSIS N, LIEBSCHER J, VARVOUNIS G. Synthesis of (E)-3-(1H-Pyrrol-3-yl)prop-2-ene derivatives using organo-phosphorous reagents [J]. Paper, 2006, 9:1494-1498.
[14]
MEHTA G, DHAR D N, SURI S. Reaction of indoles with chlorosulphonyl isocyanate; a versatile route to 3-substituted indoles [J]. Synthesis, 1978, 5:374-376.
[15]
TURNBULL K, GROSS K C, HALL T A. Direct carboxamidation of sydnones with chlorosulfonyl isocyanate[J]. Synthetic Commun, 1998, 28(5):931-937.
2026年第57卷第4期
105
31
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2026.04.006
  • 接收时间:2025-05-12
  • 首发时间:2026-11-05
  • 出版时间:2026-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-05-12
基金
安顺市“两城三基地”青年科技人才培养项目(安市科人〔2024〕8号)
安顺市人民医院2026年度市级科研重点项目(安市科医自〔2026〕2号)
安顺市科技局平台建设项目(安市科平〔2024〕04号)
作者信息
    1.贵州省安顺市人民医院药学实验室,贵州 安顺 561000
    2.贵州省瀑植缘生物科技有限公司,贵州 安顺 561000

通讯作者:

晏晨,主任药师,从事天然产物化学与药物化学研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.04.006
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏